Skip to main content

MoneyWorks4Me

Cipla informs about quarterly statement of investor complaints

21 Oct 2016 Evaluate

Cipla has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1880.50
Dr. Reddys Labs. 1378.70
Cipla 1400.00
Lupin 2010.00
Zydus Lifesciences 1197.70
View more..